Incannex Healthcare Inc. 8-K

What Happened

• Incannex Healthcare Inc. (IXHL) announced it received a letter from Nasdaq on March 16, 2026 stating the company has cured the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Rule) and is now in compliance. The company previously reported the deficiency in Form 8‑K filings dated April 23, 2025 and October 21, 2025.
• The company issued a press release on March 17, 2026 announcing the compliance cure (attached as Exhibit 99.1 to the 8‑K).

Key Details

• Nasdaq notice date: March 16, 2026 (Listing Qualifications Department).
• Rule referenced: Nasdaq Listing Rule 5550(a)(2) — Minimum Bid Price Rule.
• Prior related filings: Form 8‑K on April 23, 2025 and Form 8‑K on October 21, 2025.
• Press release issued: March 17, 2026 (Exhibit 99.1).

Why It Matters

• Restoring compliance with Nasdaq’s minimum bid price rule confirms IXHL meets a key listing standard, which helps maintain its Nasdaq listing and ongoing market access. The 8‑K does not report any financial results, management changes, or other corporate actions — it solely documents the cure of the prior bid price deficiency. Investors should monitor future SEC filings and market activity for any additional developments.